A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) C07K 14/245 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2225788
There is disclosed the use, as an agent in the treatment or the prevention of an autoimmune disease, of: (i) an agent having GM-1 binding activity, other than Ctx or Etx, or the B subunits of Ctx and Etx; or (ii) an agent having an effect on GM-1 mediated intracellular signalling events, but no GM-1 binding activity. These agents may also be used in the treatment of human T cell leukaemia, in the prevention of transplant rejection or GVHD or in a vaccination method for vaccinating a mammalian subject.
L'invention concerne l'utilisation des agents suivants dans le traitement ou la prévention d'une maladie auto-immune : i) un agent pouvant se lier à GM-1, autre que Ctx ou Etx, ou les sous-unités B de Ctx et d'Etx; ou ii) un agent ayant un effet sur la signalisation intracellulaire liée à GM-1 mais ne pouvant se lier à GM-1. Ces agents peuvent également être utilisés pour traiter les leucémies à lymphocytes T chez l'humain, pour prévenir le rejet pouvant survenir après une greffe ou la réaction du greffon contre l'hôte, ou encore pour la vaccination de mammifères.
Hirst Timothy Raymond
Nashar Toufic Osman
Williams Neil Andrew
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Oratol Limited
Trident Pharmaceuticals Inc.
LandOfFree
Therapeutic agents and autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agents and autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents and autoimmune diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1455013